JP2019503356A5 - - Google Patents

Download PDF

Info

Publication number
JP2019503356A5
JP2019503356A5 JP2018532435A JP2018532435A JP2019503356A5 JP 2019503356 A5 JP2019503356 A5 JP 2019503356A5 JP 2018532435 A JP2018532435 A JP 2018532435A JP 2018532435 A JP2018532435 A JP 2018532435A JP 2019503356 A5 JP2019503356 A5 JP 2019503356A5
Authority
JP
Japan
Prior art keywords
group
optionally
formula
alkyl
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018532435A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019503356A (ja
JP7074673B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/068075 external-priority patent/WO2017112792A1/en
Publication of JP2019503356A publication Critical patent/JP2019503356A/ja
Publication of JP2019503356A5 publication Critical patent/JP2019503356A5/ja
Priority to JP2022078995A priority Critical patent/JP7458681B2/ja
Application granted granted Critical
Publication of JP7074673B2 publication Critical patent/JP7074673B2/ja
Priority to JP2024041282A priority patent/JP2024073581A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018532435A 2015-12-22 2016-12-21 エンドソーマルｇタンパク質共役受容体のトリパータイト・モジュレーター Active JP7074673B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022078995A JP7458681B2 (ja) 2015-12-22 2022-05-12 エンドソーマルｇタンパク質共役受容体のトリパータイト・モジュレーター
JP2024041282A JP2024073581A (ja) 2015-12-22 2024-03-15 エンドソーマルｇタンパク質共役受容体のトリパータイト・モジュレーター

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2015905333 2015-12-22
AU2015905333A AU2015905333A0 (en) 2015-12-22 Modulators of Endosomal G Protein-Coupled Receptors
US201662291161P 2016-02-04 2016-02-04
US62/291,161 2016-02-04
PCT/US2016/068075 WO2017112792A1 (en) 2015-12-22 2016-12-21 Tripartite modulators of endosomal g protein-coupled receptors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022078995A Division JP7458681B2 (ja) 2015-12-22 2022-05-12 エンドソーマルｇタンパク質共役受容体のトリパータイト・モジュレーター

Publications (3)

Publication Number Publication Date
JP2019503356A JP2019503356A (ja) 2019-02-07
JP2019503356A5 true JP2019503356A5 (enExample) 2020-02-06
JP7074673B2 JP7074673B2 (ja) 2022-05-24

Family

ID=59091175

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018532435A Active JP7074673B2 (ja) 2015-12-22 2016-12-21 エンドソーマルｇタンパク質共役受容体のトリパータイト・モジュレーター
JP2022078995A Active JP7458681B2 (ja) 2015-12-22 2022-05-12 エンドソーマルｇタンパク質共役受容体のトリパータイト・モジュレーター
JP2024041282A Pending JP2024073581A (ja) 2015-12-22 2024-03-15 エンドソーマルｇタンパク質共役受容体のトリパータイト・モジュレーター

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022078995A Active JP7458681B2 (ja) 2015-12-22 2022-05-12 エンドソーマルｇタンパク質共役受容体のトリパータイト・モジュレーター
JP2024041282A Pending JP2024073581A (ja) 2015-12-22 2024-03-15 エンドソーマルｇタンパク質共役受容体のトリパータイト・モジュレーター

Country Status (8)

Country Link
US (3) US11324832B2 (enExample)
EP (1) EP3393519A1 (enExample)
JP (3) JP7074673B2 (enExample)
CN (2) CN115531553A (enExample)
AU (3) AU2016377658B2 (enExample)
CA (1) CA3009325A1 (enExample)
EA (1) EA201891472A1 (enExample)
WO (1) WO2017112792A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2770050C2 (ru) 2015-03-04 2022-04-14 Ванда Фармасьютиклз Инк. Способ лечения с применением традипитанта
EA201891472A1 (ru) * 2015-12-22 2018-12-28 Такеда Фармасьютикал Компани Лимитед Тройные модуляторы эндосомальных рецепторов, сопряженных с g-белком
WO2017197463A1 (en) * 2016-05-20 2017-11-23 Monash University Treatment of pain
DK3710000T3 (da) * 2017-11-17 2025-06-16 Vanda Pharmaceuticals Inc Tradipitant til anvendelse til behandling af gastroparese
IT202200018768A1 (it) * 2022-09-14 2024-03-14 Alberto Chiarugi Trattamento della nausea e vomito da chemioterapia
IT202200018780A1 (it) * 2022-09-14 2024-03-14 Alberto Chiarugi Modulatori degli effetti della chemioterapia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1035115B1 (en) * 1999-02-24 2004-09-29 F. Hoffmann-La Roche Ag 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists
IL144851A0 (en) * 1999-02-24 2002-06-30 Hoffmann La Roche 3-phenylpyridine derivatives and their use as nk-1 receptor antagonists
US7696168B2 (en) * 2000-04-21 2010-04-13 Tufts Medical Center, Inc. G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same
TWI287003B (en) * 2000-07-24 2007-09-21 Hoffmann La Roche 4-phenyl-pyridine derivatives
TWI259180B (en) * 2000-08-08 2006-08-01 Hoffmann La Roche 4-Phenyl-pyridine derivatives
EP1732612B1 (en) * 2004-04-08 2009-09-16 Jado Technologies GmbH Tripartite conjugates containing a structure interacting with cell membrane rafts and their use
US20060004195A1 (en) 2004-06-30 2006-01-05 Xiaohu Deng Alpha,beta-unsaturated esters and acids by stereoselective dehydration
TW200606152A (en) * 2004-07-02 2006-02-16 Tanabe Seiyaku Co Piperidine compound and process for preparing the same
BR112013007566A2 (pt) * 2010-09-28 2016-08-02 Panacea Biotec Ltd novos compostos bicíclicos
WO2014168721A2 (en) * 2013-04-12 2014-10-16 Tufts Medical Center Methods and systems for designing and/or characterizing soluble lipidated ligand agents
EP3018126A4 (en) 2013-07-03 2016-12-07 Takeda Pharmaceuticals Co HETEROCYCLIC CONNECTION
EA201891472A1 (ru) * 2015-12-22 2018-12-28 Такеда Фармасьютикал Компани Лимитед Тройные модуляторы эндосомальных рецепторов, сопряженных с g-белком

Similar Documents

Publication Publication Date Title
JP2010521485A5 (enExample)
JP5149620B2 (ja) ２価リンカーおよびその結合体
ES2777626T3 (es) Sulfonilureas y compuestos relacionados y uso de los mismos
ES2378776T3 (es) Derivado de ácido aminocarboxílico y uso medicinal del mismo
HRP20130900T1 (hr) Derivat (aza)indola i njegova uporaba u medicinske svrhe
ES2615481T3 (es) Antagonistas de glucagón
JP2008513496A5 (enExample)
AR082995A1 (es) Profarmacos que comprenden un conjugado de conector de exendina
JP2009504763A5 (enExample)
EA201000157A1 (ru) Неосновные антагонисты рецептора меланин-концентрирующего гормона 1 типа и их применение
MX2012001399A (es) Profarmacos que comprenden un conjugado de insulina-conector.
HRP20120327T1 (hr) Supstituirani indolil alkil amino derivati kao novi inhibitori histonske deacetilaze
BRPI0515372B8 (pt) composição líquida para fornecer anestesia local prolongada após administração a um indivíduo, e, uso de bupivacaína, acetato isobutirato de sacarose e álcool benzílico
EP2423207A3 (en) 2-(cyclic amino)-pyrimidone derivatives as TPK1 inhibitors
JP2013533253A5 (enExample)
JP2008195730A5 (enExample)
JP2013503862A5 (enExample)
JP2013540114A5 (enExample)
JP2011517453A5 (enExample)
EA201171109A1 (ru) Новая композиция замедленного высвобождения соединений, выбранных из класса миорелаксантов центрального действия
CY1111275T1 (el) Κρυσταλλικη μορφη μιας ενωσης κινολινονης-καρβοξαμιδιου
EP2682387A3 (en) C7-fluoro substituted tetracycline compounds
RU2008152763A (ru) Применение агонистов каннабиноидного рецептора в качестве индуцирующих гипотермию лекарственных средств для лечения ишемии
PE20081837A1 (es) Derivados de quinuclinidol como antagonistas de los receptores muscarinicos
ATE520651T1 (de) Substituierte phenylmethylbicyclocarbonsäureamidverbindungen